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Background:Aortic elastic properties are determinants of left ventricular function bymeans of ventriculo-arterial
coupling and indicators of cardiovascular risk. Aortic valve stenosis surgical replacement temporary reduces
aortic function damaging vasa vasorum, while transcatheter aortic valve implantation (TAVI) does not inﬂuence
it in the short term. We studied aortic distensibility, stiffness, M-mode strain and tissue strain after 6 and
12 months from TAVI.
Methods:Weenrolled 15 patients with symptomatic severe aortic stenosiswho underwent CoreValve prosthesis
(Medtronic, Minneapolis, MN) implantation. Everyone had blood pressure measurement and echocardiography
registration before TAVI and after 6 and 12 months.
Results: After TAVI NYHA class (p= 0.016), peak andmean aortic valve gradients (p b 0.001 for both) improved.
Aortic distensibility increased (p = 0.032 in the ﬁrst 6 months, p = 0.005 in the second 6 months, and
p = 0.003 frombaseline to 12 months), aswell as stiffness decreased (p= 0.034; 0.090; 0.001),M-mode strain
and tissue strain ameliorated (p= 0.041; 0.004; 0.004; and p= 0.013; 0.002; 0.001, respectively), tissue Dopp-
ler imaging improved (S′wave: p= 0.289; 0.347; 0.018. E′wave: p= 0.018; 0.113; 0.007. A′wave: p= 0.002;
0.532; 0.001). Moreover, some left ventricular parameters improved at 6 months, such as ejection fraction (from
49± 16 to 57± 11%; p= 0.044) and diastolic interventricular septum thickness (from 14 ± 2 to 12 ± 2 mm;
p = 0.010). Even systolic pulmonary artery pressure (p= 0.019) and left diastolic dysfunction grade ameliorated
(p = 0.042).
Conclusions: For the ﬁrst time we demonstrated that aortic elastic properties improve at 6 and 12 months after
TAVI, thus inﬂuencing ventriculo-arterial coupling and ameliorating left ventricular function.
© 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Aortic elastic properties are important determinant of left ventricu-
lar function by means of ventriculo-arterial coupling. They also inﬂu-
ence coronary blood ﬂow and are independent prognostic factors of
cardiovascular risk [1,2]. Geometry of aorta, qualities of its wall, pres-
sure in it, autonomic nervous system and perfusion via vasa vasorum
ﬂow: all determine aortic elastic properties [3–5]. Therefore, they are
altered in several pathologic conditions involving aorta and aortice reliability and freedom from
ion.
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is an open access article under the Cvalve [6–10]. Aortic valve stenosis is a quite frequent valvular disease
which could require a surgical treatment [11,12]. It could be done in
open or transcatheter. Open chest surgery is still considered the gold
standard for symptomatic patients, but recently transcatheter aortic
valve implantation (TAVI) is an option for patients at high surgical risk
[13–18]. After open surgery vasa vasorum are removed or damaged,
so that various studies reported a reduction of aortic elastic properties;
vice versa TAVI do not alter them [19–21]. Insofar, it is reasonable to
hypothesize that elastic aortic propertiesmay remain stable or improve
after the procedure. A recent work by Vavuranakis M et al. in fact found
that seven days after TAVI aortic distensibility and stiffness do not
change [22]. However, to date, no studies have been published with a
longer follow-up (for example 6 or 12 months). In addition, none
have evaluated TAVI effects on aortic elastic properties by means of
M-mode strain and tissue strain of aortic wall. The aim of the presentC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Table 1
Baseline characteristics of study populations.
Variable Value
Age (years) 83 ± 5
Sex (n and % of males) 6/15 (40.0%)
BMI (kg/m2) 25.86 ± 4.24
BSA (m2) 1.79 ± 0.14
Logistic EuroSCORE (%) 28.1 ± 20.8
Valsalva sinuses diameter (mm) 35 ± 4
Sinotubular junction diameter (mm) 27 ± 4
Tubular tract diameter (mm) 35 ± 5
Aortic arch diameter (mm) 24 ± 3
Indexed aortic valve area (cm2/m2) 0.33 ± 0.15
Maximal aortic ﬂow velocity (m/s) 4.7 ± 0.6
BMI = Body Mass Index; BSA = Body Surface Area; EuroSCORE = European System for
Cardiac Operative Risk Evaluation Score.
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tissue strain 6 and 12 months after TAVI comparedwith pre-procedural
ones.
2. Methods
2.1. Subjects
From January 2011 to August 2011we consecutively enrolled 15 pa-
tients with symptomatic severe aortic stenosis and left ventricular ejec-
tion fraction N45% who underwent successful TAVI at the Cardiologic
Unit of University Civil Hospital of Brescia, Italy.
Patients were treated with TAVI if the aortic valve area was b1 cm2,
if the European System for Cardiac Operative Risk Evaluation Score
(EuroSCORE) [23] was N20% or if ≥1 of the following criteria was
met: contraindication for surgery, severely reduced pulmonary func-
tion, liver cirrhosis, or metastatic cancer.
All patients underwent TAVI procedure with a third-generation
self-expanding CoreValve prosthesis (Medtronic, Minneapolis, MN).
The procedure was performed at the catheterization laboratory under
local anesthesia andmild sedationwith ﬂuoroscopy guidance. The pros-
thesis was implanted via the transfemoral approach [13]. Procedural
success was deﬁned as implantation of a functioning aortic prosthesis
valve without intraprocedural mortality and with a paravalvular leak
b2.
Written informed consent was obtained from each patient after the
explanation of rationale and studyprotocol. The investigational protocol
was conformed in accordance with the ethical standards laid down in
the 1964 Declaration of Helsinki and its later amendments and was
approved by the institutional committee.
The pre-procedural echocardiography acquisition was performed
the same day of the procedure.
2.2. Blood pressure measurement
Blood pressure was assessed using a standard, calibrated sphygmo-
manometer. The mean of three sitting and standing blood pressures
was recorded. The arm in which the highest sitting diastolic pressures
found was the arm used for all subsequent readings throughout the
study. Every effort was made to have the same staff member obtain
blood pressure measurements in each individual patient, at the same
time of day, using the same equipment. Systolic pressure was recorded
when the initial sound is heard (Phase I of the Korotkoff sound), while
diastolic pressure at the disappearance of the sound (Phase V of the
Korotkoff sound). The cuff was deﬂated at a rate not greater than
2 mm Hg/s.
2.3. Echocardiography
Echocardiograms were done using Vivid 7 (General Electric Medical
Systems, Milwaukee, WI, USA) equipment with a 3.5 MHz transducer,
with the patients in the left lateral decubitus position, in accordance
with the standardization of the American Society of Echocardiography
[24]. Digital loops were stored on the hard disk of the echocardiograph
for on-line and off-line analyses and transferred to a workstation
(EchoPac; GE Health-care, Waukesha, WI, USA) for off-line analysis.
Left ventricular volumes and ejection fraction were obtained by the
modiﬁed biplane Simpson method. Aortic valve parameters and left
ventricular diastolic function were also evaluated. All these parameters
were analyzed the day of the procedure before it and 6 months later,
while aortic elastic properties were evaluated even 12 months after
TAVI.
All conventional and tissue Doppler imaging (TDI) measurements
were taken in ﬁve consecutive cycles and the means were used for
statistical comparison. Aortic size was assessed at four levels: Valsalva
sinuses, sinotubular junction, tubular tract, and aortic arch at the endof diastole. Aortic elastic indexes: distensibility, and stiffness index
were calculated from the echocardiographically-derived thoracic aortic
diameters (mm/m2). Aortic elasticity was assessed on the basis of a 2D
guided M-mode recording of systolic (AoS) and diastolic (AoD) aortic
diameters, 3 cm above the aortic valve. AoD was obtained at the
peak of the R wave at the simultaneously recorded ECG, and AoS
was measured at the maximal anterior motion of the aortic wall.
The following indexes of aortic elasticity were calculated: aortic dis-
tensibility = [2 × (AoS− AoD) / (AoD × PP)] (10−6 × cm2 × dyn−1);
aortic stiffness index = ln(SBP / DBP) / [(AoS − AoD) / AoD] (pure
number) where SBP and DBP refer to brachial systolic and diastolic
blood pressure respectively, in mm Hg; pulse pressure (PP) was
calculated as SBP–DBP, and ln(SBP / DBP) refers to the natural loga-
rithm of the relative pressure [25]. Parasternal long-axis recordings
of the aortic anterior wall were done with activated TDI. Two-
dimensional tissue velocity images of the aortic wall were obtained
at 130± 15 frames/s, which implies a temporal resolution of approx-
imately 16 ms. The velocity scale was modiﬁed to avoid aliasing. A
sample volume was placed in the region of interest on the anterior
aortic wall (3 cm above the aortic valve at the same position as in
M-mode measurements). TDI wall velocities during systole (S′), early
relaxation (E′) and atrial systole (A′) were measured. Velocity data
sets were analyzed off-line using dedicated software (EchoPac; GE
Health-care, Waukesha, WI, USA), and peak systolic strain was mea-
sured from the resulting deformation curves.
2.4. Statistical analysis
All analyses were carried out using IBM SPSS Statistics 20 for
Windows (SPSS, Inc., Chicago, IL). Continuous variables were tested
for normality with Kolmogorov–Smirnov test and represented by
mean± standard deviation, while categorical variables as frequency
(n) and percentage of the sample. Paired-samples t test was performed
to analyze the difference between means for continuous variables be-
tween baseline, 6 months and 12 months follow-up, and χ2 test for
the difference between proportions for categorical ones. For all statisti-
cal tests, probability values b0.05 were considered signiﬁcant.
3. Results
The characteristics at baseline are summarized in Tables 1 and 2. The
mean agewas 83±5 years, 6 patientsweremale (40.0%) and the Logis-
tic EuroSCORE was 28.1 ± 20.8%. Mean Body Mass Index (BMI) was
25.86 ± 4.24 kg/m2. All patients were symptomatic: 5 in New York
Heart Association (NYHA) class II (33.3%), 8 in NYHA class III (53.3%)
and2 inNYHAclass IV (13.4%). The peak andmeanbaseline transvalvular
gradient were 83± 28mmHg and 49± 19mmHg, respectively. Calcu-
lated indexed aortic valve area at baseline was 0.33 ± 0.15 cm2/m2 and
maximal aortic ﬂow velocity was 4.7 ± 0.6 m/s2. Baseline dimensions
of aorta were: Valsalva sinus diameter of 35 ± 4 mm, sinotubular
Table 2
Blood pressure, heart rate and NYHA class.
Variable 0 months 6 months p
SBP (mm Hg) 121 ± 10 120 ± 9 0.096
DBP (mm Hg) 71 ± 8 70 ± 9 0.164
HR (bpm) 74 ± 11 75 ± 11 0.670
NYHA class I: 0/15 (0.0%) I: 3/15 (20.0%) 0.016
II: 5/15 (33.3%) II: 10/15 (66.7%)
III: 8/15 (53.3%) III: 2/15 (13.3%)
IV: 2/15 (13.4%) IV: 0/15 (0.0%)
SBP = Systolic Blood Pressure; DBP = Diastolic Blood Pressure; HR = Heart Rate;
NYHA = New York Heart Association.
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and aortic arch diameter of 24 ± 3 mm. At 6 months of follow-up
NYHA class improved to 3 patients in NYHA class I (20.0%), 10 in NYHA
class II (66.7%), and 2 inNYHA class III (13.3%) (p= 0.016), while systolic
and diastolic blood pressures and heart rate remained unchanged.
A complete study dataset was available in all patients: the echocar-
diographic parameters evaluated at baseline and during follow-up
of 6 months are summarized in Table 3. There were signiﬁcant
periprocedural reductions in peak (to 19 ± 8 mm Hg; p b 0.001) and
mean (to 10 ± 5 mm Hg; p b 0.001) transvalvular gradients. Left
ventricular ejection fraction improved from 49 ± 16% to 57 ± 11%
(p = 0.044), while end-diastolic and end-systolic volumes not sig-
niﬁcantly decreased (from 112 ± 45 to 108 ± 39 mL, p = 0.530;
from 59 ± 43 to 45 ± 19 mL, p = 0.167; respectively). Indexed left
ventricular mass decreased from 181.8 ± 38.4 to 166.4 ± 38.7 g/m2
without reaching statistical signiﬁcance (p = 0.202), as well as tele-
diastolic diameter, systolic and diastolic posterior wall thickness and
systolic interventricular septum thickness not signiﬁcantly improved.
Only diastolic intraventricular septum thickness signiﬁcantly decreases
after 6 months (from 14±2 to 12±2mm, p= 0.010). Finally, systolic
pulmonary artery pressure was signiﬁcantly reduced by the procedure
(from40±12 to 28±9mmHg, p= 0.019), but Swave on left ventric-
ular lateral wall increased without statistical signiﬁcance.
Patients who underwent TAVI showed an improvement in left ven-
tricular diastolic function during 6 months follow-up (see Table 3). In
fact, at baseline 9 patients had grade I (60.0%), 5 grade II (33.3%), and
1 grade III (6.7%), while after 6 months from TAVI procedure 3 had nor-
mal diastolic function (20.0%), 11 grade I (73.3%), and 1 grade III (6.7%)
(p= 0.042). Nevertheless, mitral ﬂow and left ventricular TDI parame-
ters did not show statistically signiﬁcant changes from baseline.Table 3
Echocardiographic parameters.
Variable 0 months
Diastolic IVST (mm) 14 ± 2
Systolic IVST (mm) 16 ± 4
Diastolic PWT (mm) 14 ± 3
Systolic PWT (mm) 18 ± 3
End-diastolic diameter (mm) 56 ± 8
Indexed left ventricular mass (g/m2) 181.8 ± 38.4
End-diastolic volume (mL) 112 ± 45
End-systolic volume (mL) 59 ± 43
Ejection fraction (%) 49 ± 16
Peak aortic valve gradient (mm Hg) 83 ± 28
Mean aortic valve gradient (mm Hg) 49 ± 19
E wave 0.93 ± 0.33
A wave 0.79 ± 0.40
E/A 1.41 ± 0.95
Deceleration time 217 ± 67
E′ wave 3.00 ± 1.29
A′ wave 5.64 ± 0.75
S′ wave 5.67 ± 1.62
E/E′ 41.81 ± 30.68
Systolic pulmonary artery pressure (mm Hg) 40 ± 12
IVST = InterVentricular Septum Thickness; PWT = Posterior Wall Thickness.In Table 4 and Fig. 1 aortic elastic properties are resumed, reporting
baseline, 6 and 12 months of follow-up parameters. TDI S′ wave
signiﬁcantly improved after 12 months, changing from 5.17 ± 1.37 at
baseline to 5.68 ± 1.18 cm/s (p = 0.018), but not after 6 months
(9.77 ± 16.70 cm/s; p value from baseline to 6 months: 0.289;
p value from 6 to 12 months: 0.347). TDI E′ and A′ waves signif-
icantly improved only in the ﬁrst 6 months, respectively moving
from −4.42 ± 2.55 to −5.57 ± 2.37 cm/s (p = 0.018) and
from −6.28 ± 2.27 to −4.76 ± 1.89 cm/s (0.002); vice versa,
changes in from 6 to 12 months did not reach signiﬁcance, being
12-month E′ value −5.68 ± 2.20 cm/s (p = 0.113) and A′ value
−4.72 ± 1.78 (0.532). Therefore, TDI E′ and A′ waves improvement
from baseline to 12 months was statistically signiﬁcant (p = 0.007
and 0.001 respectively). Moreover, aortic distensibility showed an im-
provement from 2.24 ± 1.69 at baseline to 3.46 ± 3.03 at 6 months
(p = 0.032) to 4.14 ± 2.96 10−6 × cm2 × dyn−1 at 12 months (p from
6 to 12 months = 0.005; p from baseline to 12 months = 0.018)
and aortic stiffness decreased from 14.05 ± 7.13 at baseline to
10.30 ± 6.99 at 6 months (p = 0.034) and to 7.31 ± 4.55 at
12 months (p from 6 to 12 months = 0.090; p from baseline to
12 months= 0.001). In conclusion, aortic strain values signiﬁcantly im-
proved after 6 and 12 months. In particular, M-mode strainmoved from
5.50 ± 4.12 at baseline to 8.67 ± 8.16 at 6 months (p = 0.041) and to
10.41 ± 8.03% at 12 months (p from 6 to 12 months and from baseline
to 12 months = 0.004), while tissue strain from−14.0 ± 9.2 at base-
line to −17.2 ± 7.5 at 6 months (p = 0.013) and to −19.9 ± 6.3%
at 12 months (p from 6 to 12 months = 0.002; p from baseline to
12 months = 0.001).
Finally, we compared aortic distensibility, stiffness, M-mode strain
and tissue strain variations from baseline to 6 months with them from
6 to 12 months of follow-up (Table 5).We found that therewere no sta-
tistical differences between them.
4. Discussion
This study conﬁrms data reported by Vizzardi E et al. in 2012 regard-
ing left ventricular diastolic function and mass [26]. However, to our
knowledge, this is the ﬁrst study consideringmid-term follow-up aortic
elastic properties changes (6 and 12 months) after a TAVI, and the ﬁrst
using M-mode strain and tissue strain of aortic wall. Recently,
VavuranakisMet al. demonstrated that 7 days after the procedure aortic
distensibility and stiffness remain unchanged [22], in contrast with the
early post-surgical period (open chest) inwhich aortic vasa vasorumare6 months p
12 ± 2 0.010
17 ± 3 0.812
12 ± 3 0.127
19 ± 4 0.565
58 ± 9 0.131
166.4 ± 38.7 0.202
108 ± 39 0.530
45 ± 19 0.167
57 ± 11 0.044
19 ± 8 b0.001
10 ± 5 b0.001
0.82 ± 0.38 0.390
0.88 ± 0.42 0.513
1.28 ± 1.10 0.678
215 ± 39 0.911
3.43 ± 1.40 0.356
5.21 ± 1.58 0.356
6.15 ± 0.76 0.364
22.02 ± 5.28 0.134
28 ± 9 0.019
Table 4
Aortic elastic properties.
Variable 0 months p (0–6 months) 6 months p (6–12 months) 12 months p (0–12 months)
S′ wave (cm/s) 5.17 ± 1.37 0.289 9.77 ± 16.70 0.347 5.68 ± 1.18 0.018
E′ wave (cm/s) −4.42 ± 2.55 0.018 −5.57 ± 2.37 0.113 −5.68 ± 2.20 0.007
A′ wave (cm/s) −6.28 ± 2.27 0.002 −4.76 ± 1.89 0.532 −4.72 ± 1.78 0.001
Distensibility (10−6 × cm2 × dyn−1) 2.24 ± 1.69 0.032 3.46 ± 3.03 0.005 4.14 ± 2.96 0.003
Stiffness 14.05 ± 7.13 0.034 10.30 ± 6.99 0.090 7.31 ± 4.55 0.001
M-mode strain (%) 5.50 ± 4.12 0.041 8.67 ± 8.16 0.004 10.41 ± 8.03 0.004
Tissue strain (%) −14.0 ± 9.2 0.013 −17.2 ± 7.5 0.002 −19.9 ± 6.3 0.001
Fig. 1. Aortic elastic properties (p values reported in Table 4).
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tion decreases [19–21]. Albeit our study enrolled only 15 people
with severe symptomatic aortic stenosis, it interestingly seems to
demonstrate that aortic function really improves after TAVI at 6 and
12-month follow-up. In fact, distensibility increases, stiffness reduces
and M-Mode and tissue strains ameliorate. These data are very useful in
understandinghowaortic functionmay inﬂuence ventriculo-arterial cou-
pling and so cardiovascular risk. In fact, although our study seems under-
powered to detect statistically signiﬁcant differences in left ventricular
morphology and function, some parameters instead signiﬁcantly im-
proved 6 months after TAVI, such as diastolic interventricular septum
thickness, ejection fraction, systolic pulmonary artery pressure and
diastolic dysfunction grade. We think that these mid-term changes
could be almost partly attributed to the improving of aortic elastic prop-
erties. Further studies are needed to test this hypothesis. In fact, if why
aortic function decreases after open chest surgery is easy to understand,
vice versa why it improves after TAVI is really unclear. Perhaps theTable 5
Aortic elastic properties variations in the ﬁrst and in the second 6 months.
Variable Delta 0–6 months Delta 6–12 months p
Distensibility
(10−6 × cm2 × dyn−1)
−1.22 ± 1.98 −0.68 ± 0.79 0.369
Stiffness 3.75 ± 6.19 2.99 ± 6.36 0.793
M-mode strain (%) −3.17 ± 5.47 −1.74 ± 1.95 0.373
Tissue strain (%) 3.2 ± 4.4 2.7 ± 2.7 0.694normalization of wall stress upon the proximal aortic root due to the
drastic reduction of transvalvular gradient could be responsible of the
recovery of aortic elastic properties.
The present study shows some limitations of note. First is the small
number of patients, which limits the possibility of a more robust statis-
tical analysis. Second, improved aortic elastic properties may partly re-
ﬂect the improved ﬂow across the aortic valve, and by itself, not really
be at all a marker for improved cardiovascular risk.
In conclusion, what prognostic role this phenomenon could have is
difﬁcult to be explored because open chest surgery is still considered
the gold standard and TAVI is only an alternative to high surgical risk
patients. These ﬁndings suggest a further advantage of TAVI respect
conventional surgery.
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